Glioblastoma has a distinctive appearance on brain scans: a large, irregularly shaped mass with a bright ring of actively growing tumor surrounding a dark, dead center. This pattern, visible on contrast-enhanced MRI, is one of the most recognizable in brain imaging. But glioblastoma also has a characteristic look under the microscope and during surgery, each revealing something different about how this aggressive cancer behaves.
What Glioblastoma Looks Like on MRI
The hallmark image of glioblastoma is a ring-enhancing lesion. When contrast dye is injected during an MRI, the outer rim of the tumor lights up brightly on T1-weighted images because the dye leaks through abnormal, fast-growing blood vessels. The center of the mass stays dark because it consists of dead tissue (necrosis) that has outgrown its blood supply. This combination of bright rim and dark core is what radiologists look for first.
Surrounding the visible tumor is a halo of swelling that shows up as a bright, hazy region on a different type of MRI sequence called FLAIR. This swelling extends well beyond the enhancing ring, sometimes pushing into adjacent brain structures and shifting the brain’s midline. What makes glioblastoma particularly dangerous is that tumor cells actually infiltrate this swollen zone, so the true boundary of the cancer extends further than what any scan can clearly outline.
The tumor itself is rarely a neat sphere. It tends to grow in irregular, finger-like projections that follow the brain’s white matter tracts. One well-known pattern is the “butterfly glioma,” where the tumor crosses the corpus callosum, the thick band of nerve fibers connecting the brain’s two hemispheres. On axial (top-down) MRI slices, this creates a symmetrical mass that spreads into both sides of the brain, resembling the wings of a butterfly.
What Surgeons See During an Operation
When a neurosurgeon opens the skull and reaches a glioblastoma, the tumor’s appearance is strikingly varied, even within a single mass. Some areas are soft and yellowish, reflecting fatty breakdown of the brain’s insulating myelin. Other regions are firm and white. Patches of dark red or brown indicate hemorrhage, which is common because the tumor’s hastily built blood vessels are fragile and prone to bleeding. The necrotic center often has a pale, straw-colored look.
This patchwork quality is actually considered a defining characteristic. Few brain tumors show such dramatic variation in color and texture from one spot to the next. Surgeons may also encounter cystic areas filled with fluid, adding yet another visual element. The edges of the tumor blend into normal-looking brain tissue, making it impossible to distinguish cancer from healthy brain by sight alone.
What Glioblastoma Looks Like Under a Microscope
Two microscopic features separate glioblastoma from all lower-grade brain tumors: pseudopalisading necrosis and microvascular proliferation. Both are required for a pathologist to confirm the diagnosis.
Pseudopalisading necrosis refers to a pattern where dying tissue sits at the center of a small zone, and living tumor cells line up in dense rows around it, like a fence. For nearly a century this was thought to be a passive arrangement, but more recent work has shown that these cells are actively migrating away from oxygen-starved areas. They’re essentially fleeing a dead zone, and the “fence” pattern is a snapshot of that movement. This feature predicts aggressive behavior.
Microvascular proliferation is the other hallmark. Glioblastoma triggers explosive blood vessel growth. Under the microscope, new vessels appear as dense tangles of rapidly dividing cells, sometimes forming ball-shaped structures called glomeruloid bodies because they resemble the filtering units in kidneys. These abnormal vessels are what allow contrast dye to leak on MRI, creating that characteristic bright ring. They’re also structurally defective, which is why glioblastomas bleed so easily.
How Fast the Tumor Changes
Glioblastoma grows fast enough that its appearance on scans can change noticeably within weeks. Research measuring tumor volume over time found a median daily growth rate of 1.4%, with a volume doubling time of roughly 50 days. Smaller tumors grow faster than larger ones. As the mass expands, it increasingly outstrips its blood supply, so growth follows a pattern of initial acceleration that gradually slows as more of the tumor’s interior becomes necrotic.
This rapid growth is part of why over half of patients have a clinical history of less than three months from first symptom to diagnosis. The most common symptoms that lead to discovery are seizures and cognitive changes. Other signs include progressive weakness on one side of the body, vision problems, language difficulties, headaches, and personality changes. Because some of these symptoms overlap with dementia or depression, the tumor can initially be misattributed to other conditions.
What Else Can Look Like Glioblastoma on a Scan
Several other conditions produce ring-enhancing masses with surrounding swelling, making them difficult to tell apart from glioblastoma on a standard MRI. The two most common mimics are brain metastases (cancers that have spread from elsewhere in the body) and brain abscesses (pockets of infection).
All three can appear as rim-enhancing masses with prominent surrounding edema. To distinguish them, radiologists use specialized MRI techniques. One measures how easily water molecules move within the lesion’s core: abscesses typically restrict water movement because they’re filled with thick pus, while necrotic tumors allow water to move more freely. However, this rule has exceptions in both directions, with some abscesses showing high water movement and some tumors showing low movement.
Another technique measures blood volume in the enhancing rim. Glioblastomas and metastases have significantly higher blood volume in their rims than abscesses do, because tumor-driven blood vessel growth creates dense vascular networks that infections don’t produce. Combining these advanced imaging methods with clinical context, such as whether a patient has a known cancer elsewhere or a recent infection, helps narrow the diagnosis before tissue is ever removed for biopsy.